2022
DOI: 10.1016/j.hrcr.2022.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Advanced atrioventricular block due to hypervagotonia: Treatment with hyoscyamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Hyoscyamine is mainly used to relieve stomach spasm, muscle spasms, arterial spasm, ulcer pain and other blood circulation diseases ( Dehghan et al., 2017 ). Hyoscyamine has also been reported to effectively treat hypervagotonia causing advanced AV block, as a muscarinic receptor blocker, and it is an attractive treatment option for patients with hypervagotonia, as it can substitute permanent pacemaker implant ( Mai and Kusumoto, 2022 ). According to previous reports, hyoscyamine is produced from hyoscyamine aldehyde through enzymatic reaction lead by hyoscyamine dehydrogenase.…”
Section: Pharmacologically Important Secondary Metabolites Production...mentioning
confidence: 99%
“…Hyoscyamine is mainly used to relieve stomach spasm, muscle spasms, arterial spasm, ulcer pain and other blood circulation diseases ( Dehghan et al., 2017 ). Hyoscyamine has also been reported to effectively treat hypervagotonia causing advanced AV block, as a muscarinic receptor blocker, and it is an attractive treatment option for patients with hypervagotonia, as it can substitute permanent pacemaker implant ( Mai and Kusumoto, 2022 ). According to previous reports, hyoscyamine is produced from hyoscyamine aldehyde through enzymatic reaction lead by hyoscyamine dehydrogenase.…”
Section: Pharmacologically Important Secondary Metabolites Production...mentioning
confidence: 99%